BDSI - BioDelivery Sciences International, Inc.
| Previous Close | 3.8000 |
| Open | 3.8700 |
| Bid | 3.9000 x 1800 |
| Ask | 3.9100 x 900 |
| Day's Range | 3.8600 - 4.0900 |
| 52 Week Range | 2.3500 - 5.3700 |
| Volume | 947,640 |
| Avg. Volume | 1,059,170 |
| Market Cap | 349.103M |
| Beta (3Y Monthly) | -0.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5940 |
| Earnings Date | Aug 7, 2019 - Aug 12, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.21 |
- TheStreet.com•10 hours ago
3 Small-Caps That Look Like Bargains at Current Trading Levels
No resolution seems on the horizon on the U.S.-China trade front as both sides have dug in their heels. Since the end of February the S&P 500 has continued to advance despite a pullback in May, while the Russell 2000 has stalled out. Let's look at three small-caps that seem like good bargains at current trading levels, starting with BioDelivery Sciences International Inc. .
- GlobeNewswire•8 days ago
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.S. RALEIGH, N.C., July.
- Zacks•14 days ago
Perrigo Completes Ranir Acquisition, Raises '19 Guidance
Perrigo (PRGO) completes previously announced acquisition of Ranir. The company raised guidance for adjusted earnings to include accretion of 10 cents from Ranir.
- Zacks•14 days ago
Top Ranked Momentum Stocks to Buy for July 3rd
Top Ranked Momentum Stocks to Buy for July 3rd
- Zacks•14 days ago
Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance
Amarin announces strong preliminary sales of Vascepa in the second quarter. The company increases sales guidance for 2019.
- Benzinga•19 days ago
18 Stocks Joining The Russell Indices
The Russell 2000 Index is a small-cap stock market index that includes the bottom 2,000 companies found in the Russell 3000 index. The Russell Microcap Index includes the 1,000 smallest securities found ...
- Zacks•19 days ago
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
- Zacks•20 days ago
Focus on 4 Liquid Picks on the Top Rung for Robust Returns
Here are four top-ranked liquid stocks that investors can cling on to for significant returns.
- Zacks•22 days ago
What Makes BioDelivery (BDSI) a New Strong Buy Stock
BioDelivery (BDSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
- GlobeNewswire•23 days ago
BioDelivery Sciences Expands Upon Report from Pain Management Task Force
Company’s Activities Support Buprenorphine Recommendations Including: Primary Use of Buprenorphine in Chronic Pain when Clinically IndicatedHaving Payers Provide Coverage and.
- Zacks•26 days ago
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
- Zacks•27 days ago
5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints
The Fed has said that adoption of more accommodative policy is gaining ground as some economic developments raised concerns about U.S. and global growth.
- GlobeNewswire•27 days ago
BioDelivery Sciences Named to the Russell 3000® Index
RALEIGH, N.C., June 20, 2019 -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is set to be added to the broad-market Russell 3000® Index as well as the Russell 2000®.
- Insider Monkey•27 days ago
Here’s What Hedge Funds Think About BioDelivery Sciences International, Inc. (BDSI)
The market has been volatile in the last 6 months as the Federal Reserve continued its rate hikes and then abruptly reversed its stance and uncertainty looms over trade negotiations with China. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF […]
- Zacks•last month
Why Is BioDelivery (BDSI) Down 12.3% Since Last Earnings Report?
BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- American City Business Journals•2 months ago
Triangle company uses new financial strength to lock down favorable loan
A renegotiated loan agreement will bring a Triangle public company $20 million more credit – but it also spells a remarkable transformation in the company's financial position.
- GlobeNewswire•2 months ago
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
RALEIGH, N.C., May 29, 2019 -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to.
- GlobeNewswire•2 months ago
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
New Agreement is Cash Flow Accretive, Lowers Cost of Capital and Extends Debt Maturity Reduces Annual Interest Costs by Approximately $1.5 million Increases Flexibility to.
- Simply Wall St.•2 months ago
Can You Imagine How Chuffed BioDelivery Sciences International's (NASDAQ:BDSI) Shareholders Feel About Its 108% Share Price Gain?
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
- Zacks•2 months ago
The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology
The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology
- Zacks•2 months ago
5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon
Trade-war resistant stocks such as biotechs would be the first to benefit from a relief rally.
- Zacks•2 months ago
All You Need to Know About BioDelivery (BDSI) Rating Upgrade to Buy
BioDelivery (BDSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of BDSI earnings conference call or presentation 6-May-19 8:30pm GMT
Q1 2019 BioDelivery Sciences International Inc Earnings Call
- Zacks•2 months ago
BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat
BioDelivery (BDSI) incurs narrower-than-expected loss in Q1. Sales surpass the consensus mark. The company raises guidance for 2019.
Motley Fool•2 months agoBioDelivery Sciences International, Inc. (BDSI) Q1 2019 Earnings Call Transcript
BDSI earnings call for the period ending March 31, 2019.
